featured
ERBB2 mRNA Expression Is Associated With Response to T-DM1 in HER2+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancers
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer
Cancers (Basel) 2020 Jul 14;[EPub Ahead of Print], G Griguolo, F Brasó-Maristany, B González-Farré, T Pascual, N Chic, T Saurí, R Kates, O Gluz, D Martínez, L Paré, V Tsvetkova, D Pesantez, M Vidal, B Adamo, M Muñoz, P Galván, L Barberá, M Cuatrecasas, M Christgen, H Kreipe, I Monge-Escartín, P Villagrasa, D Soy, T Giarratano, MV Dieci, P Conte, N Harbeck, V Guarneri, A PratFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.